Improved Lifetime of Bio-Monolith Protein A Columns for Titer Determination

Application Note Biopharma mAb Titer Determination in 60 Seconds Using the Agilent Bio‑Monolith rProtein A Column High-throughput clonal selection for process development and process optimization Authors Dr. Te-Wei Chu and Ivan Huang Agilent Technologies, Inc. Introduction The Agilent Bio-Monolith rProtein…

Application Note Biopharma Robust, Reliable, Recombinant Protein A Monolith Column for Antibody Titer Determination Authors Te-Wei Chu and Andrew Coffey Agilent Technologies, Inc. Abstract Rapid screening of crude cell culture supernatant allows decisions to be made on the optimum time…

Bio-Monolith Protein G Column More Options for mAb Titer Determination Application Note Biologics and Biosimilars Author Introduction Phu T. Duong In recent years, monoclonal antibodies (mAbs) have become one of the major biopharma products in response to the need to…

mAb Titer Analysis with the Agilent Bio-Monolith Protein A Column Application Note Biopharmaceuticals and Biosimilars Authors Abstract Emmie Dumont, Isabel Vandenheede, Monoclonal antibodies (mAbs) are becoming increasingly important in the Pat Sandra, and Koen Sandra treatment of various diseases. During…